Emergent BioSolutions (EBS) Change in Inventory (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Change in Inventory of -$15.8 million for Q1 2026, down 818.18% year-over-year from $2.2 million in Q1 2025, and down 11.27% quarter-over-quarter from -$14.2 million in Q4 2025.
Emergent BioSolutions (EBS) Change in Inventory (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Change in Inventory history runs 17 years deep, the most recent figure standing at -$15.8 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 818.18% year-over-year to -$15.8 million; the TTM figure through Mar 2026 stood at $12.3 million (down 44.59% YoY), while the FY2025 annual figure was $30.3 million, up 23.67% from the prior year.
- Change in Inventory for Q1 2026 stood at -$15.8 million, down from -$14.2 million in the prior quarter.
- The five-year high for Change in Inventory was $50.1 million in Q1 2022, with the low at -$127.7 million in Q4 2022.
- The 5-year median for Change in Inventory is $4.5 million (2024), against an average of $794117.6.
- The sharpest annual moves came in 2022 and 2024: Change in Inventory slumped 1584.88% in 2022, then jumped 17900.0% in 2024.
- Emergent BioSolutions' Change in Inventory stood at -$127.7 million in 2022, then surged by 79.95% to -$25.6 million in 2023, then soared by 57.03% to -$11.0 million in 2024, then slipped by 29.09% to -$14.2 million in 2025, then retreated by 11.27% to -$15.8 million in 2026.
- Business Quant data shows EBS's Change in Inventory at -$15.8 million in Q1 2026, -$14.2 million in Q4 2025, and $17.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -24.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.00 Mn |
| Jun 30, 2026 | -24.00 Mn |
| Mar 31, 2026 | -15.80 Mn |
| Mar 31, 2026 | -15.80 Mn |
| Dec 31, 2025 | -14.20 Mn |
| Dec 31, 2025 | -14.20 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Jun 30, 2025 | 24.70 Mn |
| Jun 30, 2025 | 24.70 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | -11.00 Mn |
| Dec 31, 2024 | -11.00 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.50 Mn |